INFLAMMATORY MARKERS CRP, FERRITIN, TUMOUR NECROSIS FACTOR ALPHA IN PREECLAMPSIA.
Main Article Content
Keywords
.
Abstract
Preeclampsia (PE) is one of the most serious pregnancy complications. The worldwide prevalence of PE ranges from 3 to 7% of pregnancies, affecting a total of 8.5 million women worldwide.PE is responsible for about 18% of maternal deaths and up to 40% of fetal mortality. At this time, PE still lacks a safe and effective therapy, as well as a reliable, early means of diagnosis or prediction.
References
2) de Jonge LL, Steegers EA, Ernst GD, Lindemans J, Russcher H, Hofman A, Jaddoe VW. C-reactive protein levels, blood pressure and the risks of gestational hypertensive complications: the Generation R Study.J Hypertens. 2011;29:2413–2421.
3) Ertas IE, Kahyaoglu S, Yilmaz B, Ozel M, Sut N, Guven MA, DanismanN. Association of maternal serum high sensitive C-reactive protein level with body mass index and severity of pre-eclampsia at third trimester.J Obstet Gynaecol Res. 2010;36:970–977.
4) Akkurt MO, Akkurt I, Altay M, Coskun B, Erkaya S, Sezik M. Maternal serum ferritin as a clinical tool at 34-36 weeks’ gestation for distinguishing subgroups of fetal growth restriction. J Maternal-Fetal Neonatal Med. 2017;30(4):452-6.
5) Rifaha D, Akhter N, Rahman R, Khan NJ, Akter S, Jannat YD, et al. Serum Ferritin and Serum Iron Level in Preeclampsia. Sch Int J Obstet Gynec. 2023;6(5):182-7.
6) Rebelo F, Schlüssel MM, Vaz JS, Franco-Sena AB, Pinto TJ, Bastos FI, Adegboye AR, Kac G. C-reactive protein and later preeclampsia: systematic review and meta-analysis taking into account the weight status. J Hypertens. 2013;31:16–26.
7) Sibai B, Romero R, Klebanoff MA, et al. Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. American Journal of Obstetrics and Gynecology. 2009;200(6):630.
8) Amaral LM, Wallace K, Owens M, LaMarca B. Pathophysiology and current clinical management of preeclampsia. Curr Hypertens Rep. 2017 Aug;19(8):61.
9) Das S, Das R, Bajracharya R, Baral G, Jabegu B, Odland JØ, et al. Incidence and risk factors of pre-eclampsia in the Paropakar Maternity and Women’s Hospital, Nepal: a retrospective study. Int J Environ Res Public Health. 2019 Sep;16(19):3571.
10) Kristensen K, Wide-Swensson D, Lindstrom V, Schmidt C, Grubb A, Strevens H. Serum amyloid a protein and C-reactive protein in normal pregnancy and preeclampsia. Gynecol Obstet Invest. 2009;67(4):275–80.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Ms. Shubhangi H Gawade
Tutor, Department of Biochemistry, SKNMCGH, PUNE
Dr. Pooja N Joshi
Lecturer, Department of Biochemistry, BJGMC, PUNE
Dr. Gouri A Gulavani
Associate professor, Department of Biochemistry, SKNMCGH, PUNE
Ms. Farheen Mujawar
Tutor, Department of Biochemistry, SKNMCGH, PUNE